Incisional Negative Pressure Therapy Following High Risk Direct Anterior Total Hip Arthroplasty .
Randomized Controlled Trial of Incisional Negative Pressure Following High-Risk Direct Anterior Total Hip Arthroplasty
J Arthroplasty. 2022 Aug;37(8S): S931-S936.One hundred and twenty patients undergoing total hip arthroplasty using the direct anterior approach were randomized to receive either closed incisional negative pressure therapy (ciNPT; n=60) or a silver-impregnated hydrofiber dressing (n=60). The primary outcomes of this trial were wound healing and surgical site complications 90 days postoperation. Additional outcomes such as debridement, the use of antibiotics, return to OR, and aspiration of a hematoma or seroma were also assessed. No significant differences in overall surgical site complication rate were observed, however, significantly more patients in the control group had a superficial surgical site infection, and more patients in the control group required topical antibiotics vs. the ciNPT group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
